T1	Outcomes 1084 1090	years.
T2	Outcomes 1091 1110	The median dose per
T3	Outcomes 1302 1361	IM800 achieved major molecular remission and deep molecular
T4	Outcomes 1456 1518	patients achieved remissions much later than younger patients.
T5	Outcomes 1519 1541	Grades 3 and 4 adverse
T6	Outcomes 1570 1581	age groups.
T7	Outcomes 1582 1600	Five-year relative
